JPRN-UMIN000010944已完成3 期
CAP for ANCA-associated vasculitis presenting with rapidly progressive glomerulonephritis - LCAP for AAV
Department of Hemovascular Medicine and Artificial Organs, Faculty of Medicine, University of Miyazaki0 个研究点目标入组 20 人开始时间: 2013年6月13日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
CAP might be useful for mild cases with ANCA vasculitis. However, registered cases were small, and statistical evaluation could not be done.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. WBC and Plt counts lower than 3000/mm3 and 100,000/mm3, respectively 2. history of allergic reaction to FOY 3. severe cardiovascular, liver, lung, metabolic, neurologic or infectious diseases 4. prescription of ACEI 5. recent history of plasmapheresis
研究者
相似试验
招募中
不适用
Biocollection of Patients With ANCA Associated VasculitisANCA-associated VasculitisNCT05364892University Hospital, Brest100
进行中（未招募）
不适用
Abatacept in ANCA associated vasculitis: ABAVAS - ABAVASAnti-neutrophil cytoplasmic antibody (ANCA) associated vasculitisMedDRA version: 8.1Level: LLTClassification code 10050894Term: Anti-neutrophil cytoplasmic antibody positive vasculitisEUCTR2006-001859-35-DEImperial College London112
进行中（未招募）
1 期
Abatacept in ANCA associated vasculitis: ABAVAS - ABAVASEUCTR2006-001859-35-NLImperial College London
进行中（未招募）
1 期
Abatacept in ANCA associated vasculitis: ABAVAS - ABAVASEUCTR2006-001859-35-GBImperial College London
进行中（未招募）
不适用
SE OF ABATACEPT IN ANCA-ASSOCIATED VASCULITIS - ABAVASEUCTR2008-004138-26-ITAZIENDA OSPEDALIERA DI PARMA112